Difference in Baseline Antimicrobial Prescription Patterns of Hospitals According to Participation in the National Antimicrobial Monitoring and Feedback System in Korea.

IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Jihye Shin, Ji Young Park, Jungmi Chae, Hyung-Sook Kim, Song Mi Moon, Eunjeong Heo, Se Yoon Park, Dong Min Seo, Ha-Jin Chun, Yong Chan Kim, Myung Jin Lee, Kyungmin Huh, Hyo Jung Park, I Ji Yun, Su Jin Jeong, Jun Yong Choi, Dong-Sook Kim, Bongyoung Kim
{"title":"Difference in Baseline Antimicrobial Prescription Patterns of Hospitals According to Participation in the National Antimicrobial Monitoring and Feedback System in Korea.","authors":"Jihye Shin, Ji Young Park, Jungmi Chae, Hyung-Sook Kim, Song Mi Moon, Eunjeong Heo, Se Yoon Park, Dong Min Seo, Ha-Jin Chun, Yong Chan Kim, Myung Jin Lee, Kyungmin Huh, Hyo Jung Park, I Ji Yun, Su Jin Jeong, Jun Yong Choi, Dong-Sook Kim, Bongyoung Kim","doi":"10.3346/jkms.2024.39.e216","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to evaluate the differences in the baseline characteristics and patterns of antibiotic usage among hospitals based on their participation in the Korea National Antimicrobial Use Analysis System (KONAS). We obtained claims data from the National Health Insurance for inpatients admitted to all secondary- and tertiary-care hospitals between January 2020 and December 2021 in Korea. 15.9% (58/395) of hospitals were KONAS participants, among which the proportion of hospitals with > 900 beds (31.0% vs. 2.6%, <i>P</i> < 0.001) and tertiary care (50.0% vs. 5.2%, <i>P</i> < 0.001) was higher than that among non-participants. The consumption of antibiotics targeting antimicrobial-resistant gram positive bacteria (33.7 vs. 27.1 days of therapy [DOT]/1,000 patient-days, <i>P</i> = 0.019) and antibiotics predominantly used for resistant gram-negative bacteria (4.8 vs. 3.7 DOT/1,000 patient-days, <i>P</i> = 0.034) was higher in KONAS-participating versus -non-participating hospitals. The current KONAS data do not fully represent all secondary- and tertiary-care hospitals in Korea; thus, the KONAS results should be interpreted with caution.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 29","pages":"e216"},"PeriodicalIF":3.0000,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286329/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Korean Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3346/jkms.2024.39.e216","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

This study aimed to evaluate the differences in the baseline characteristics and patterns of antibiotic usage among hospitals based on their participation in the Korea National Antimicrobial Use Analysis System (KONAS). We obtained claims data from the National Health Insurance for inpatients admitted to all secondary- and tertiary-care hospitals between January 2020 and December 2021 in Korea. 15.9% (58/395) of hospitals were KONAS participants, among which the proportion of hospitals with > 900 beds (31.0% vs. 2.6%, P < 0.001) and tertiary care (50.0% vs. 5.2%, P < 0.001) was higher than that among non-participants. The consumption of antibiotics targeting antimicrobial-resistant gram positive bacteria (33.7 vs. 27.1 days of therapy [DOT]/1,000 patient-days, P = 0.019) and antibiotics predominantly used for resistant gram-negative bacteria (4.8 vs. 3.7 DOT/1,000 patient-days, P = 0.034) was higher in KONAS-participating versus -non-participating hospitals. The current KONAS data do not fully represent all secondary- and tertiary-care hospitals in Korea; thus, the KONAS results should be interpreted with caution.

韩国参与国家抗菌药物监测和反馈系统的医院抗菌药物处方基线模式的差异。
本研究旨在评估参与韩国国家抗菌药物使用分析系统(KONAS)的医院在抗生素使用的基线特征和模式方面的差异。我们从国民健康保险中获得了 2020 年 1 月至 2021 年 12 月期间韩国所有二级和三级医院住院患者的报销数据。15.9%(58/395)的医院是KONAS的参与者,其中床位数大于900张的医院(31.0% vs. 2.6%,P < 0.001)和三级医疗机构(50.0% vs. 5.2%,P < 0.001)的比例高于非参与者。参与 KONAS 的医院与未参与的医院相比,针对耐药革兰氏阳性菌的抗生素消耗量(33.7 对 27.1 治疗天数 [DOT] /1,000 患者日,P = 0.019)和主要用于耐药革兰氏阴性菌的抗生素消耗量(4.8 对 3.7 DOT/1,000患者日,P = 0.034)更高。目前的 KONAS 数据并不完全代表韩国所有的二级和三级医院,因此在解释 KONAS 结果时应谨慎。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Korean Medical Science
Journal of Korean Medical Science 医学-医学:内科
CiteScore
7.80
自引率
8.90%
发文量
320
审稿时长
3-6 weeks
期刊介绍: The Journal of Korean Medical Science (JKMS) is an international, peer-reviewed Open Access journal of medicine published weekly in English. The Journal’s publisher is the Korean Academy of Medical Sciences (KAMS), Korean Medical Association (KMA). JKMS aims to publish evidence-based, scientific research articles from various disciplines of the medical sciences. The Journal welcomes articles of general interest to medical researchers especially when they contain original information. Articles on the clinical evaluation of drugs and other therapies, epidemiologic studies of the general population, studies on pathogenic organisms and toxic materials, and the toxicities and adverse effects of therapeutics are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信